Actionable news
All posts from Actionable news
Actionable news in EVOK: Evoke Pharma, Inc.,

Four Companies To Consider for Your Portfolio in August 2016 Briefing: The Fed held its two-day meeting this week and after much deliberation, the decision has been made to leave rates where they are for right now. The guidance came after identifying that the current economic state is still relatively unstable while the outlook for the global economic unrest mainly rippling from Brexit have still some uncertainty. Despite this outlook on the economy, the decision actually has spurred interest in many stocks this morning with many "bottomed out" equities seeing price reversals including:

Life Clips, Inc. (OTC: LCLP) (OTCQB: LCLP), which is a lifestyle brand focused on "capturing life's moments" through a mix of electronics and charging devices. The flagship Solo Vu 4K action camera is pitted directly against higher priced competitors like GoPro to offer a much more affordable and higher quality action camera. Life Clips also holds ownership of Mobeego, a single use electronics charger or "energy shot" for your devices like smart phones and action cams.

This morning the company announced that it has reached a distribution agreement with Mr. Checkout Distributors. The agreement essentially allows Life Clips the access to roughly 35,000 store around the United States. Furthermore, Mr. Checkout has a long list of big box channel partners like Wal Mart, Kmart, Home Depot, and more. Since making the announcement this morning, shares of LCLP have recovered by as much as 14.6% since Wednesday's closing price.

Evoke Pharma (NASDAQ: EVOK) has also seen a stronger rally in price since drastically gapping down a few weeks back. Since reporting abnormal results from a Phase 3 clinical trial of the company's EVK-001, the stock has struggled a bit but recent news that EVOK received conditional FDA acceptance of a proposed brand name for EVK-001 seems to have revived the stock. On Thursday morning, shares of EVOK saw highs of $3.09 and marked a recovery of more than 100% from July lows of $1.52.

The FDA has conditionally...